Healthcare
•3762 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3762)
| Company | Market Cap | Price |
|---|---|---|
|
SNSE
Sensei Biotherapeutics, Inc.
Sensei's lead asset targets oncology/cancer indications, fitting the Biotech - Oncology category.
|
$11.56M |
$9.15
-0.22%
|
|
BRTX
BioRestorative Therapies, Inc.
BRTX-100 is an autologous mesenchymal stem cell therapy, the company's lead cell therapy product for disc disease.
|
$11.56M |
$1.50
-2.27%
|
|
LIXT
Lixte Biotechnology Holdings, Inc.
LB-100 is Lixte's lead oncology drug candidate (PP2A inhibitor) being developed for cancer therapy, constituting the primary product/offerable asset.
|
$11.51M |
$4.36
+1.63%
|
|
LUDG
Ludwig Enterprises, Inc.
Development of non-invasive diagnostic tests/biomarker-based technology qualifies as medical devices & biometrics.
|
$11.38M |
$0.07
|
|
MRKR
Marker Therapeutics, Inc.
Marker Therapeutics develops MAR-T cell therapies, a cell-based immunotherapy platform targeting cancer.
|
$11.18M |
$0.96
-3.02%
|
|
IXHL
Incannex Healthcare Limited
Incannex develops oral small-molecule therapeutics as fixed-dose drug combinations (IHL-42X).
|
$11.10M |
$0.36
-5.17%
|
|
COCP
Cocrystal Pharma, Inc.
Cocrystal Pharma is actively developing antiviral small-molecule therapeutics (CC-42344, CDI-988, CC-31244) for influenza, norovirus/coronavirus, and HCV.
|
$11.09M |
$1.08
-0.46%
|
|
BOLT
Bolt Biotherapeutics, Inc.
Bolt is a clinical-stage biotech focused on oncology immunotherapies, making 'Biotech - Oncology' a core investable theme.
|
$11.04M |
$5.76
|
|
IMRN
Immuron Limited
Core polyclonal antibody technology platform powering gut-health products and clinical programs in immunology/biotherapeutics.
|
$10.83M |
$1.99
+4.74%
|
|
SEED
Origin Agritech Limited
Origin provides breeding services and collaborative R&D through a service consortium, aligning with Contract Research Organizations.
|
$10.71M |
$1.64
-2.96%
|
|
SCNX
Scienture Holdings, Inc.
Arbli (SCN-102) is a cardiovascular drug (losartan liquid formulation) indicated for hypertension and related conditions.
|
$10.18M |
$0.70
-9.32%
|
|
PALI
Palisade Bio, Inc.
PALI-2108 is an orally administered small molecule therapeutic, matching the Oral Small Molecule Therapeutics tag.
|
$9.93M |
$1.98
-4.59%
|
|
PHIO
Phio Pharmaceuticals Corp.
INTASYL is based on RNA interference (siRNA), making RNAi therapeutics a core product/framework.
|
$9.84M |
$1.83
-10.73%
|
|
BGLC
BioNexus Gene Lab Corp.
VitaGuard MRD is a tumor-naïve liquid biopsy platform used in BGLC's MRNA Scientific diagnostics, defining a liquid biopsy product category.
|
$9.74M |
$5.63
+3.97%
|
|
GELS
Gelteq Limited Ordinary Shares
Gelteq's core offering is a gel-based drug delivery platform used across nutraceuticals, pet care, sports, OTC, and pharmaceutical products.
|
$9.58M |
$1.08
-8.47%
|
|
XAIR
Beyond Air, Inc.
LungFit is a medical device platform that generates nitric oxide and is sold/distributed to hospitals.
|
$9.56M |
$1.95
-5.34%
|
|
RNAZ
TransCode Therapeutics, Inc.
TransCode Therapeutics operates in biotech oncology, developing cancer therapeutics.
|
$9.34M |
$10.78
-3.75%
|
|
TNON
Tenon Medical, Inc.
Catamaran SI Joint Fusion System and related SI implants are orthopedic devices sold as implants for sacroiliac fusion.
|
$9.11M |
$1.19
-0.83%
|
|
APYP
AppYea, Inc.
AppySleep devices function as medical devices/biometrics for sleep disorders.
|
$9.09M |
$0.02
|
|
EPIX
ESSA Pharma Inc.
Directly describes a biotech company focused on oncology drug development (masofaniten) with no revenue; core business is cancer therapeutics.
|
$8.93M |
$0.20
|
|
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
The company operates a software-driven planning/diagnostic workflow used in radiology/medical imaging, which can be associated with the diagnostic equipment category.
|
$8.92M |
$0.62
+0.02%
|
|
GOVX
GeoVax Labs, Inc.
GeoVax directly develops and manufactures vaccines using its MVA platform for infectious diseases (Mpox/smallpox and COVID-19 programs).
|
$8.60M |
$0.56
-0.12%
|
|
EVGN
Evogene Ltd.
Biomica's microbiome therapeutics program (BMC128) targets human health, fitting Immunology Therapeutics within Biotech.
|
$8.56M |
$1.25
-1.19%
|
|
SYNX
Silynxcom Ltd.
Vital signs monitoring headset positions the product within medical devices/biometric sensing.
|
$8.33M |
$1.62
-1.29%
|
|
BLRX
BioLineRx Ltd.
BioLineRx's lead oncology asset motixafortide (APHEXDA) places the company squarely in oncology with an approved stem cell mobilization therapy and ongoing cancer indications development.
|
$8.32M |
$3.43
-1.15%
|
|
HCWC
Healthy Choice Wellness Corp.
HCWC runs licensed wellness centers offering services such as IV nutrient drips, i.e., Healthcare Services & Facilities.
|
$8.23M |
$0.60
-0.03%
|
|
CBIO
Crescent Biopharma, Inc.
Crescent Biopharma focuses on oncology therapeutics, explicitly mentioning next-gen cancer biologics and its lead PD-1 x VEGF bispecific and ADCs.
|
$8.23M |
$12.25
-3.92%
|
|
TSBX
Turnstone Biologics Corp.
Company's core business is oncology-focused biotechnology, including immunotherapy approaches (TIL-based strategies) in solid tumors.
|
$8.21M |
$0.35
|
|
CELZ
Creative Medical Technology Holdings, Inc.
CELZ develops autologous/allogeneic cell therapies (ImmCelz and AlloStem), a core cell therapy business.
|
$8.20M |
$3.07
-3.15%
|
|
CHEK
Check-Cap Ltd.
The company’s legacy C-Scan system is a diagnostic equipment product category (capsule-based CRC screening).
|
$8.13M |
$1.38
-1.08%
|
|
SBFM
Sunshine Biopharma, Inc.
SBFM's Nora Pharma operates a growing Canadian generic prescription drug business.
|
$8.06M |
$1.67
-5.65%
|
|
SINT
Sintx Technologies, Inc.
Core business is manufacturing medical-grade silicon nitride materials used in medical devices, aligning with Medical Devices & Biometrics.
|
$8.00M |
$3.37
+5.64%
|
|
APM
Aptorum Group Limited
Diagnostics platform potentially operating as a network of clinical labs; reflects lab-based service delivery.
|
$7.88M |
$1.43
-1.04%
|
Showing page 34 of 38 (3762 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
